Activation of Innate and Adaptive Immune Responses by a Ginseng Extract
AssigneeAfexa Life Sciences Inc.
InventorsDarryl J. Adamko, Kenneth L. Rosenthal, Jacqueline Shan, Yingqi Wu, Sharla Sutherland
Life of this patent
Estimating the term…
Abstract
The invention is directed to ginseng fractions and methods for activating innate and adaptive immune responses to prevent, treat or ameliorate a condition in a subject by administering to the subject an effective amount of a ginseng traction, a pharmaceutical composition comprising the fraction in combination with another medicament or with one or more pharmaceutically acceptable carriers, or a food item comprising the fraction. The fraction may be made from Panax quinquefolius or may be selected from CVT-E002, PQ2, PQ223 and purified fractions from CVT-E002, PQ2, and PQ223.
Claims13
A method of preventing, treating or ameliorating airway inflammation, airway hyperresponsiveness, or a combination thereof, in a subject having a condition characterized by airway inflammation, airway hyperresponsiveness, or a combination thereof, comprising administering to the subject an effective amount of at least one ginseng fraction, wherein the ginseng fraction is prepared from a water soluble extract of the root portion of Panax quinquefolius and is substantially identical to a fraction selected from the group consisting of CVT-E002, PQ2, PQ223, a purified fraction from CVT-E002, a purified fraction from PQ2 and a purified fraction from PQ223.
Dependencies are inferred from the claim text.